Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02101645
Other study ID # R13148
Secondary ID
Status Completed
Phase N/A
First received February 26, 2014
Last updated May 12, 2015
Start date March 2014
Est. completion date December 2014

Study information

Verified date May 2015
Source Tampere University Hospital
Contact n/a
Is FDA regulated No
Health authority Finland: PSHP Ethics CommitteeFinland: National Supervisory Authority for Wellfare and Health (Valvira).
Study type Interventional

Clinical Trial Summary

The research group will choose no more than 10 patients having a lower extremity venous ulcer(s), less than 5cm diameter and with an estimated one month time of re-epithelization. In this study the investigators will follow and monitor the healing of the wound and effectiveness of compression therapy using bioimpedance measurement based method. The investigators will also treat the wounds using periodical low intensity direct current (LIDC) stimulation therapy.

Bioimpedance monitoring and wound stimulation functionalities are provided by a purpose built wound patch. The patch features a printed 4 x 4 stimulation and impedance measurement electrodes array (in contact with wound surface) surrounded by a 4-part dual purpose counter and impedance reference electrodes (in contact with the intact skin surrounding the wound area).


Description:

Objectives of the study

Primary: Proof-of-concept study of bioimpedance measurement based method for monitoring of chronic wound healing and assessment of efficacy of compression therapy. Gathering bioimpedance data from the patients with a lower extremity ulcer of venous etiology over their healing process. The investigators will seek methods for processing the collected data to find the best correlation with visually observed healing of the wound.

Secondary: Proof-of-concept study of periodical LIDC wound stimulation. The investigators will compare the LIDC enhanced healing outcome with appropriate archived data of previous studies performed in TAYS.

Other: Analysis of the received data and reliability evaluation of the methods. Gathering relevant user feedback from medical personnel and patients.


Recruitment information / eligibility

Status Completed
Enrollment 6
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Male or female patients with a chronic wound of venous origin.

- Patients have signed consent to participate in the study.

- Patient is motivated to follow the instructions given by medical personnel and research group.

- Age 18 - 80 years.

- Wound(s) is expected to heal significantly during the period of 2 months.

- Wound(s) is located so that there is enough space to place the experimental wound dressing appropriately.

- Diameter of a single wound is no more than 5 cm and wound edges are not steep. If patient has multiple small wounds, the wounds are located within an area of 5x5cm.

- Patient has adequate vascular supply and patient tolerates compression dressings.

Exclusion Criteria:

- Patient has an unstable coronary disease.

- Subject does not approve the informed consent.

- Subject is not appropriately motivated to follow M.D.'s instructions of treatment (at home).

- Participation in another clinical trial that involves an investigational drug or device that would interfere this study.

- Patient suffers from cognitive problem such as dementia.

- Wound is not expected to be healed during the time reserved for the measurements (circa 2 months).

- Patient has active wound infection or increased risk of wound infection.

- Skin changes or skin disease which could alter the epidermis of the electrode site during the measurement period.

- Patient has cancer or other life threatening disease in an unstable condition.

- Patient is pregnant.

- Patients with implantable electrical device. Such as pacemaker or implanted defibrillator.

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Procedure:
Periodical low intensity direct current (LIDC) stimulation of wound.
Wound is stimulated using LIDC current. Stimulation current magnitude is in micro-ampere range. Stimulation sequence is 1 hour on and 1 hour off for 72 hours or 96 hours.
Compression therapy of swollen limbs.
Compression bandage is used for reducing swelling of the limbs.

Locations

Country Name City State
Finland Tampere University Hospital Tampere

Sponsors (4)

Lead Sponsor Collaborator
Tampere University Hospital Aalto University, Åbo Akademi University, University of Tampere

Country where clinical trial is conducted

Finland, 

References & Publications (5)

Blount AL, Foster S, Rapp DA, Wilcox R. The use of bioelectric dressings in skin graft harvest sites: a prospective case series. J Burn Care Res. 2012 May-Jun;33(3):354-7. doi: 10.1097/BCR.0b013e31823356e4. — View Citation

Carley PJ, Wainapel SF. Electrotherapy for acceleration of wound healing: low intensity direct current. Arch Phys Med Rehabil. 1985 Jul;66(7):443-6. — View Citation

Ward L, Winall A, Isenring E, Hills A, Czerniec S, Dylke E, Kilbreath S. Assessment of bilateral limb lymphedema by bioelectrical impedance spectroscopy. Int J Gynecol Cancer. 2011 Feb;21(2):409-18. doi: 10.1097/IGC.0b013e31820866e1. — View Citation

Weber SA, Gehin C, Moddy G, Jossinet J, McAdams ET. Characterisation of a multi-frequency wound impedance mapping instrument. Conf Proc IEEE Eng Med Biol Soc. 2008;2008:4907-10. doi: 10.1109/IEMBS.2008.4650314. — View Citation

Zhao M, Song B, Pu J, Wada T, Reid B, Tai G, Wang F, Guo A, Walczysko P, Gu Y, Sasaki T, Suzuki A, Forrester JV, Bourne HR, Devreotes PN, McCaig CD, Penninger JM. Electrical signals control wound healing through phosphatidylinositol-3-OH kinase-gamma and — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Patient and personnel questionaire results. After the final patient visit, a questionaire will be given to patients and personnel. Questionaire will provide the research group valuable information for further development of the study method and equipment. 2 months No
Primary 2-electrode bioimpedance data of wound and intact skin. 4-electrode bioimpedance data related to local interstitial fluid status of affected leg. We aim to determine how well bioimpedance measurement based method for monitoring of chronic wound healing and assessment of efficacy of compression therapy comply with the results of conventional wound monitoring methods.
We will measure the impedance of the wound and intact skin from multiple locations using 2-electrode configuration. To obtain this a purpose built electrode array will be placed on the wound, covering also area of intact skin. The electrode array will also be used for determining the interstitial fluid status of the leg by 4-electrode impedance measurement.
4 months No
Secondary Low intensity direct current stimulation of wound. We will compare the LIDC enhanced healing outcome with appropriate archived data of previous studies performed in Tampere University Hospital. 4 months Yes